Latest News

Bottom row: From left, Vinata B. Lokeshwar, Ph.D., Luis Lopez and Norman Altman, V.M.D. Top row: From left, Soum Lokeshwar, Andre Jordan and Georgios Kallifatidis, Ph.D.

Bottom row: From left, Vinata B. Lokeshwar, Ph.D., Luis Lopez and Norman Altman, V.M.D. Top row: From left, Soum Lokeshwar, Andre Jordan and Georgios Kallifatidis, Ph.D.

Sylvester Researchers Report Prevention of Lethal Prostate Cancer with 4-MU Dietary Supplement

In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer. Additionally the agent was able to halt the metastatic spread of the disease.

“We found that 4-methylumbelliferone (4-MU) was able to block a key signaling pathway that triggers the development, growth and metastasis of prostate cancer,” said the study’s principal investigator Vinata B. Lokeshwar, Ph.D., professor of urology and director of the pilot and translational studies component of the Miami Clinical and Translational Science Institute. “The results were simply amazing.”

Read more about the research findings »

More News

Dileep R. Yavagal, M.D.

Neurologist Helps Establish New Standard of Care for Acute Stroke Treatment

A new treatment strategy for stroke patients using a retrievable stent to open large arteries in conjunction with “clot-busting” medication can dramatically reduce long-term disability, according to a ground-breaking study published online April 17 in the New England Journal of Medicine.

Read more about the research »

From left, Eric Peterson, M.D., and Dan Brooks.

UHealth Neurosurgeon Relieves Florida Firefighter’s Mysterious Pain

Dan Brooks, an Indian River County firefighter and father of four, is not one to complain easily. Six years ago, he began experiencing pain on the side of his face. At first, it came and went, but over time the searing pain grew more intense and occurred more frequently.

Read more about the pain-relieving surgery »

From left, Richard Fain, Felicia Knaul, Ph.D., Julio Frenk, M.D., M.P.H., Ph.D., Stuart A. Miller and Pascal J. Goldschmidt, M.D.

Miller School Leaders Welcome UM President-Elect Dr. Julio Frenk

The morning after being named the next President of the University of Miami, Julio Frenk, M.D., M.P.H., Ph.D., currently Dean of Harvard University’s T.H. Chan School of Public Health, met with clinical chairs and other leadership at the Miller School of Medicine.

Read more about Dr. Julio Frenk »

Current cover of the journal Human Molecular Genetics. Video & Photo Gallery

Discovery of Critical Gene Mutation Linked to Hereditary Deafness

A gene mutation causing a form of hereditary deafness has been identified by an international team of researchers led by Xuezhong Liu, M.D., Ph.D., Leonard M. Miller Professor and Vice Chair for Research in Otolaryngology and Director of the Center for Hereditary Deafness at the University of Miami Miller School of Medicine.

Read more about the research finding »

From left, Savita Pahwa, M.D., Margaret A. Fischl, M.D., Robert C. Gallo, M.D., Mario Stevenson, Ph.D.

CFAR Symposium Explores New Frontiers of HIV Research and Therapies

The 11th annual Miami CFAR Symposium, “Confronting HIV and Its Complications,” drew nearly 200 clinicians, researchers, educators, students and pharmaceutical company representatives to hear some of the world’s leading experts present the most current information available on HIV research and therapies.

Read more about the Miami CFAR Symposium »

News & Events »

Office of the Dean

A message from the dean

Med

Read Med

e-Update

Read e-Update